Acrisure Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,652	Closed	-$17.4K	–	165
2023 Q1	$17.4K	Sell	1,652 -3,157	-66%	-$33.3K	0.02%	251
2022 Q4	$163K	Buy	+4,809	New	+$163K	0.18%	211